Navigation Links
Advanced Prostate Cancer Patients Finally Have Another Option
Date:4/29/2010

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA).

Men's Health Network (MHN) is excited to see this innovative treatment option made available for patients with asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone refractory) prostate cancer. Provenge harnesses the individual's own immune system to fight cancer through a process called active cellular immunotherapy.

Provenge offers hope for men (and their families) to potentially extend and improve the quality of life for those who are suffering from advanced prostate cancer.  Patients should work with their healthcare providers to determine if they are an appropriate candidate for Provenge at this time.

There is an immense need for more options and awareness about the plight of men with advanced prostate cancer. MHN is very excited that the approval of Provenge brings us one step closer to this goal by adding a breakthrough treatment option for these men.  Men now have an opportunity to engage in a conversation with their health care provider about this new innovative immunotherapy to potentially extend and improve their quality of life.

For more information about prostate cancer, please visit www.menshealthnetwork.org or call us at 866-543-6461, extension 101.

About Men's Health Network

Men's Health Network (www.menshealthnetwork.org) is a national non-profit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.


'/>"/>
SOURCE Men's Health Network
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available
3. MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
4. Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinsons Disease
5. VIDEO from Medialink and LSI: Advanced Technologies Make Science More Accessible
6. Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
8. Advanced Life Sciences Announces 2009 Fourth Quarter and Full Year Financial Results
9. Advanced Life Sciences to Host 2009 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
10. UAB Hospital to Integrate Advanced Symbiq(TM) Infusion Device With EHR to Enhance Safety and Clinician Workflow
11. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):